Business Wire

  1. LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform For AI-Driven Laboratory Operations 3/5/2026

    LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform.

  2. Lucent Diagnostics And Life Line Screening Partner To Bring Advanced Blood-Based Diagnostics To Communities Nationwide 3/2/2026

    Lucent Diagnostics, a brand of Quanterix Corporation today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for chronic conditions in community health settings.

  3. Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media To Help Detect Candida Infections Faster*, Including Drug-Resistant Candida Auris 3/2/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific Brilliance Candida 2 Agar and Spectra Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1.

  4. Acupath Laboratories, Inc. Partners With Azer Scientific To Install The First AzerView Digital Pathology Scanner In The United States 2/27/2026

    Three pathology and healthcare technology leaders today announced a partnership that has resulted in the installation of the first LH510 Digital Pathology scanner in the United States, marking a significant milestone in the advancement of digital pathology and diagnostic innovation.

  5. Thermo Fisher Scientific Introduces New Laboratory Developed Test To Help Transplant Patients Receive The Right Dose Of Critical Anti-Rejection Medication Sooner 2/26/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.

  6. Epredia And Mindpeak Announce EU Distribution Agreement For AI-Powered Image Recognition In Cancer Diagnostics 2/24/2026

    Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation and Mindpeak, a leading provider of artificial intelligence (AI) solutions for clinical and research pathology, today announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.

  7. Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity And Higher Cell Recovery 2/19/2026

    Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions today announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing.

  8. Meridian Life Science Expands Ambient-Stable NGS Portfolio With The Launch Of A Lyophilized Enzymatic DNA Fragmentation Kit 2/18/2026

    The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit.

  9. Project Santa Fe Foundation And Virchow Medical Announce First-Of-Its-Kind Partnership To Advance Proactive Analytics In Clinical Laboratory Medicine 2/17/2026

    The Project Santa Fe Foundation (PSFF) and Virchow Medical have formed a partnership to meet the unmet needs of oncology patients by transforming laboratory insights into proactive clinical analytics.

  10. Molecular Instruments Announces Fully Ambient-Temperature HCR™ Pro RNA-ISH On The BOND-III, Setting A New Standard For Clinical Automation 2/17/2026

    Molecular Instruments (MI), inventor of the HCR technology, today announced the availability of fully ambient-temperature HCR Pro RNA-ISH on the BOND-III, introducing a new class of clinical-grade RNA-ISH engineered for consistency, tissue preservation, and scalable automation.